Revenue - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NuVasive Inc
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Revenue
$1.2B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.8B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.2B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$21.4B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.7B
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.6B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
14%

NuVasive Inc
Revenue Breakdown

Breakdown by Geography
NuVasive Inc

Total Revenue: 1.2B USD
100%
United States: 925.9m USD
77%
Non-Us: 276.1m USD
23%

Breakdown by Segments
NuVasive Inc

Total Revenue: 1.2B USD
100%
Products: 1.1B USD
90.8%
Spinal Hardware: 909.8m USD
75.7%
Surgical Support: 292.2m USD
24.3%
Services: 111m USD
9.2%
Show More
Show Less

See Also

What is NuVasive Inc's Revenue?
Revenue
1.2B USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Revenue amounts to 1.2B USD.

What is NuVasive Inc's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for NuVasive Inc have been 5% over the past three years , 3% over the past five years , and 7% over the past ten years .

Back to Top